Skip to main content

Behҫet-like syndrome associated with aplastic anemia successfully treated with mycophenolate mofetil

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Yilmaz U, Ar MC, Esatoglu SN, Bavunoglu I, Erzin YZ, Hatemi AI, Yildirim S, Hatemi G, Celik AF (2020) How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review. Ann Hematol 99:1193–1203

    Article  Google Scholar 

  2. Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B (2008) Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47(8):1228–1230

    CAS  Article  Google Scholar 

  3. Chung JW, Cheon JH, Lee KJ, Kim JS, Jang SJ, Yang WI, Kim TI, Kim WH (2010) Aplastic anemia with trisomy 8 and trisomy 9 in intestinal behcets disease. Korean J Gastroenterol 55(4):256–260

    Article  Google Scholar 

  4. Grignano E, Jachiet V, Fenaux P, Ades L, Fain O, Mekinian A (2018) Autoimmune manifestations associated with myelodysplastic syndromes. Ann Hematol 97(11):2015–2023

    CAS  Article  Google Scholar 

  5. Köse O, Simşek I, Pay S (2011) Mycophenolate sodium in the treatment of mucocutaneous Behcet's diseases. Int J Dermatol 50(7):895–896

    Article  Google Scholar 

  6. Kappen JH, Mensink PB, Lesterhuis W, Lachman S, van Daele PL, van Hagen PM, van Laar JA (2008) Mycophenolate sodium: effective treatment for therapy-refractory intestinal Behçet's disease, evaluated with enteroscopy. Am J Gastroenterol 103(12):3213–3214

    Article  Google Scholar 

  7. Shugaiv E, Tüzün E, Mutlu M, Kiyat-Atamer A, Kurtuncu M, Akman-Demir G (2011) Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet’s disease with parenchymal involvement: presentation of four cases. Clin Exp Rheumatol 29(4 Suppl 67):S64–S67

    PubMed  Google Scholar 

  8. Stalder MP, Rovó A, Halter J, Heim D, Silzle T, Passweg J, Rischewski J, Stern M, Arber C, Buser A, Meyer-Monard S, Tichelli A, Gratwohl A (2009) Aplastic anemia and concomitant autoimmune diseases. Ann Hematol 88(7):659–665

    Article  Google Scholar 

  9. Montoro J, Gallur L, Merchán B, Molero A, Roldán E, Martínez-Valle F, Villacampa G, Navarrete M, Ortega M, Castellví J, Saumell S, Bobillo S, Bosch F, Valcárcel D (2018) Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes. Ann Hematol 97(8):1349–1356

    Article  Google Scholar 

  10. Komrokji RS, Kulasekararaj A, Al Ali NH, Kordasti S, Bart-Smith E, Craig BM, Padron E, Zhang L, Lancet JE, Pinilla-Ibarz J, List AF, Mufti GJ, Epling-Burnette PK (2016) Autoimmune diseases and myelodysplastic syndromes. Am J Hematol 91(5):E280–E283

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Krečak.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics

The patient provided informed consent for this publication. The General Hospital of Šibenik-Knin County, Croatia, does not require ethical approval for reporting individual cases or case series.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Krečak, I., Šupe, M., Ilić, I. et al. Behҫet-like syndrome associated with aplastic anemia successfully treated with mycophenolate mofetil. Ann Hematol 100, 2411–2413 (2021). https://doi.org/10.1007/s00277-020-04119-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04119-x